SEC Form 4 · accession 0001179110-18-010938
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Marino
Director
Period of report
Aug 24, 2018
Accepted (ET)
Aug 28, 2018 · 7:34 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | Aug 24, 2018 | P | 40,000 | $0.48 | A | 65,997 | D |
Table II — derivative securities
No Table II lines on this filing.